Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:MDVL MedAvail (MDVL) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About MedAvail Stock (NASDAQ:MDVL) 30 days 90 days 365 days Advanced Chart Ad Behind the MarketsMassive NVIDIA Sell-Off: Are We Headed for a Market Collapse?You may have heard about NVIDIA's CEO dumping shares of his own company. He sold 4.4 million shares this year. But here's what's even more concerning...Click here for his urgent warning - and 4 steps you need to take today to protect your retirement to Get MedAvail alerts:Sign Up Key Stats Today's Range N/A50-Day Range$1.80▼$5.9552-Week Range N/AVolume245,100 shsAverage Volume261,432 shsMarket Capitalization$2.91 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewMedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, and kiosk solutions in the United States and Canada. It offers a pharmacy technology solution, including the MedAvail MedCenter, which enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio-visual connection to a live pharmacist enabling prescription drug dispensing to occur directly to a patient with real-time supervision by a pharmacist. The company is headquartered in Phoenix, Arizona. On February 2, 2024, MedAvail Holdings, Inc along with its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.Read More… Massive NVIDIA Sell-Off: Are We Headed for a Market Collapse? (Ad)You may have heard about NVIDIA's CEO dumping shares of his own company. He sold 4.4 million shares this year. But here's what's even more concerning...Click here for his urgent warning - and 4 steps you need to take today to protect your retirement to Receive MDVL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MedAvail and its competitors with MarketBeat's FREE daily newsletter. Email Address MDVL Stock News HeadlinesDelhi Bank Corp DWNXApril 18, 2024 | morningstar.comUS Stocks Mixed; Trimble Issues Weak OutlookFebruary 12, 2024 | msn.comMassive NVIDIA Sell-Off: Are We Headed for a Market Collapse?You may have heard about NVIDIA's CEO dumping shares of his own company. He sold 4.4 million shares this year. But here's what's even more concerning...October 1, 2024 | Behind the Markets (Ad)U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.33%February 12, 2024 | msn.comMedAvail Holdings Faces Nasdaq Delisting After BankruptcyFebruary 9, 2024 | msn.comWall Street Set to Open Flat Wednesday; Jobless Claims Fall More Than ExpectedFebruary 8, 2024 | msn.comUS Futures Marginally Lower Ahead of Jobless Claims, Wholesale Trade DataFebruary 8, 2024 | msn.comU.S. shares higher at close of trade; Dow Jones Industrial Average up 0.37%February 6, 2024 | msn.comSee More Headlines MDVL Stock Analysis - Frequently Asked Questions How were MedAvail's earnings last quarter? MedAvail Holdings, Inc. (NASDAQ:MDVL) posted its quarterly earnings results on Monday, November, 8th. The company reported ($0.34) EPS for the quarter, missing the consensus estimate of ($0.32) by $0.02. The company earned $5.79 million during the quarter. MedAvail had a negative net margin of 192.97% and a negative trailing twelve-month return on equity of 218.10%. Company Calendar Last Earnings11/08/2021Today9/30/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Drug stores & proprietary stores Sub-IndustryN/A Current SymbolNASDAQ:MDVL CUSIPN/A CIK1402479 Webwww.medavail.com Phone(905) 812-0023Fax973-348-5707Employees279Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($28.72) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-47,620,000.00 Net Margins-192.97% Pretax MarginN/A Return on Equity-218.10% Return on Assets-103.45% Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$43.33 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$13.01 per share Price / BookN/AMiscellaneous Outstanding Shares1,614,000Free Float1,590,000Market Cap$2.91 million OptionableNo Data Beta0.76 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (NASDAQ:MDVL) was last updated on 10/1/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Web3 Could Send One Crypto SoaringVenture Capital corporations and blockchain funds are pouring money into Web3 gaming. And there's one littl...Crypto 101 Media | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredCentral Bank Abandons USDBillionaire investors are pouring capital into gold at rates never seen before… But what these wealthy "fat...True Gold Republic | Sponsored10X More Profitable Than Physical Gold?The smart money is piling into gold and gold stocks. There's a backdoor gold play that could deliver 10 TIM...Monument Traders Alliance | SponsoredCharles Payne’s Secrets to Surviving 2024’s Volatile MarketCharles Payne Wants You Prepared for Q4 Because as we look toward 2025, there's no denying that market vola...Unstoppable Prosperity | SponsoredFDA’s hidden signal greenlights biotech winners — 97% of the timeThe FDA has started to quietly send out a signal … That has given investors a 97% chance of making money. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MedAvail Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MedAvail With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.